Bayer (BAYGn.DE), confirmed its full-year forecast for earnings and cash flow on Monday despite slow business at its crop science and consumer health divisions.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,